Annual Cash & Cash Equivalents
$897.70 K
-$8.05 M-89.97%
December 1, 2023
Summary
- As of February 7, 2025, NLSP annual cash & cash equivalents is $897.70 thousand, with the most recent change of -$8.05 million (-89.97%) on December 1, 2023.
- During the last 3 years, NLSP annual cash & cash equivalents has risen by +$804.00 thousand (+858.06%).
- NLSP annual cash & cash equivalents is now -89.97% below its all-time high of $8.95 million, reached on December 31, 2022.
Performance
NLSP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$552.80 K
-$344.90 K-38.42%
June 1, 2024
Summary
- As of February 7, 2025, NLSP quarterly cash and cash equivalents is $552.80 thousand, with the most recent change of -$344.90 thousand (-38.42%) on June 1, 2024.
- Over the past year, NLSP quarterly cash and cash equivalents has dropped by -$1.10 million (-66.53%).
- NLSP quarterly cash and cash equivalents is now -93.82% below its all-time high of $8.95 million, reached on December 31, 2022.
Performance
NLSP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NLSP Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -90.0% | -66.5% |
3 y3 years | +858.1% | -66.5% |
5 y5 years | +10000.0% | -66.5% |
NLSP Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -90.0% | at low | -93.8% | at low |
5 y | 5-year | -90.0% | +858.1% | -93.8% | +490.0% |
alltime | all time | -90.0% | >+9999.0% | -93.8% | +8150.8% |
NLS Pharmaceutics AG Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $552.80 K(-38.4%) |
Dec 2023 | $897.70 K(-90.0%) | $897.70 K(-45.6%) |
Jun 2023 | - | $1.65 M(-81.5%) |
Dec 2022 | $8.95 M(+64.8%) | $8.95 M(+560.8%) |
Jun 2022 | - | $1.35 M(-75.1%) |
Dec 2021 | $5.43 M | $5.43 M(-23.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $7.09 M(+7468.9%) |
Dec 2020 | $93.70 K(-57.5%) | $93.70 K(-35.6%) |
Jun 2020 | - | $145.40 K(-34.0%) |
Dec 2019 | $220.30 K(+3188.1%) | $220.30 K(-82.0%) |
Jun 2019 | - | $1.22 M(>+9900.0%) |
Dec 2018 | $6700.00(-99.7%) | $6700.00 |
Dec 2017 | $2.18 M | - |
FAQ
- What is NLS Pharmaceutics AG annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual cash & cash equivalents year-on-year change?
- What is NLS Pharmaceutics AG quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly cash and cash equivalents year-on-year change?
What is NLS Pharmaceutics AG annual cash & cash equivalents?
The current annual cash & cash equivalents of NLSP is $897.70 K
What is the all time high annual cash & cash equivalents for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual cash & cash equivalents is $8.95 M
What is NLS Pharmaceutics AG annual cash & cash equivalents year-on-year change?
Over the past year, NLSP annual cash & cash equivalents has changed by -$8.05 M (-89.97%)
What is NLS Pharmaceutics AG quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NLSP is $552.80 K
What is the all time high quarterly cash and cash equivalents for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly cash and cash equivalents is $8.95 M
What is NLS Pharmaceutics AG quarterly cash and cash equivalents year-on-year change?
Over the past year, NLSP quarterly cash and cash equivalents has changed by -$1.10 M (-66.53%)